Cite
HARVARD Citation
Anastasopoulou, E. et al. (2015). DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].